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Bioactive compoundsObesity is associated with chronic low-grade inﬂammation, which has been shown to be involved in the devel-
opment of various comorbidities such as insulin resistance, glucose intolerance and liver damage. Phytochemicals
found in some spices could modulate inﬂammation and improve health problems associated with the excess of
adiposity. The extract of the Brazilian pepper Xylopia aromatica (Lam.) Mart. (CEXA) showed positive effects in
the lower dose on oral glucose tolerance, hepatic steatosis and liver inﬂammation. The higher dose of CEXA
also showed improvement on insulin sensitivity and release of anti-inﬂammatory cytokines IL-13 and IL-4 on
adipose tissue and liver. Chemical analysis revealed the presence of phenolic acids and ﬂavonoids in CEXA.
This study suggests the potential of the Brazilian pepper to attenuatemice glucose resistance and liver inﬂamma-
tion, health problems commonly associated with obesity.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Obesity is characterized by accumulation of excess fat in adipose tis-
sues to the extent of inducing adverse effects on health, which can lead
to a reduction in life expectancy and/or an increase in health hazards
(Kopelman, 2000). The incidence of obesity is recently increasing at an
enormous rate and becoming a worldwide health burden, which could
be described as the pandemic of the 21st century (Speakman, 2003).
Moreover, the excess of central adiposity is a major risk factor for the
development of type 2 diabetes, atherosclerosis, cardiovascular disease
and metabolic syndrome (Hossain, Kawar, & Nahas, 2007). The typical
Western diet, which is rich in reﬁned carbohydrates and saturated
lipids, is associated with visceral fat accumulation and the development
of obesity and its metabolic dysfunction, including insulin resistance
and hepatic steatosis (Ferreira, Mario, Porto, Andrade, & Botion, 2011;
Gregersen, Samocha-Bonet, Heilbronn, & Campbell, 2012; Rahimi &
Landaverde, 2013).rlos, 6627, Campus Pampulha,
Gerais, Belo Horizonte 31270-
andão).Conventional drug treatments of metabolic dysfunction induced by
obesity are often associated with undesirable and harmful side effects,
rebound weight gain after discontinuation of drug intake, and the inci-
dence of drug abuse. This necessitates a need of combined therapy
that is better tolerated as well as more efﬁcient (Bray & Tartaglia,
2000). The potential of natural products might provide an excellent
strategy for the scientiﬁcally based development of safe and effective
treatments. A variety of natural products, including crude extracts and
isolated compounds, have been shown to induce bodyweight reduction
and prevent diet-induced obesity and related diseases. Examples of
these constituents are polyphenols, triterpenoidal and steroidal sapo-
nins, alkaloids, and carotenoids (Devalaraja, Jain, & Yadav, 2011; Sahib
et al., 2012; Yuliana et al., 2011).
Several studies have conﬁrmed that obesity is a state of chronic in-
ﬂammation, as indicated by increased plasma concentration of proin-
ﬂammatory cytokines (Gregor & Hotamisligil, 2011; Hotamisligil,
2006). The expansion of visceral fat tissue produces a wide range of
pro- and anti-inﬂammatory mediators, both of which have been linked
to the development of insulin resistance and glucose intolerance
(Weisberg et al., 2003; Xu et al., 2003). Therefore, targeting obesity-
related inﬂammatory components may be a useful strategy to either
prevent or ameliorate the development of these obesity-related
diseases (Hirai et al., 2010).
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compounds and alkaloids commonly present in spices, canmodulate in-
ﬂammation and improve health problems associated with obesity
(Lampe, 2003;Woo et al., 2007). Black pepper, red chili, curcuma, cinna-
mon, and fenugreek are some of the spices that have been shown to
modulate many targets linked to obesity and insulin resistance
(Diwan, Poudyal, & Brown, 2011; Kang et al., 2010; Vijayakumar,
Pandey, Mishra, & Bhat, 2010). Brazil is one of the world's most biodi-
verse countries, with over 40,000 different plant species representing
20% of the world ﬂora. Among these are the fruits of Xylopia aromatica
(Lam.) Mart. (Desmarchelier, 2010), a species known as “pimenta-de-
macaco” (monkey-pepper) and found in Cerrado (Brazilian savannah).
It is used as a condiment in food, and a carminative and aphrodisiac in
traditional medicine (Corrêa, 1984; Oliveira, Yamada, Fagg, & Brandão,
2012; Silva & Rocha, 1981).
Several chemical constituents, including essential oils (Andrade,
Silva, Maia, Carreira, & Oliveira, 2004; Staschenko, Jaramillo, &
Martínez, 2004), alkaloids (Martins, Alvarenga, Roque, & Felicio,
1995; Moreira, Lago, & Roque, 2003) and phenolic compounds
(Bouba, Njintang, Scher, & Mbofung, 2010), have been reported in
the genus Xylopia. Additionally, the antioxidant, diuretic, hypoglyce-
mic and hypolipidemic properties of these plants have been shown
in some animal models (Nwozo, Orojobi, & Adaramoye, 2011;
Ogbonnia, Adekunle, Bosa, & Enwuru, 2008; Ogbonnia et al., 2010;
Somova, Shode, Moodley, & Govender, 2001). However, to the best
of our knowledge, none of these studies evaluated the fruits of
X. aromatica in laboratory studies. Here, we evaluated the potential
of this species in modulating metabolic and inﬂammatory dysfunc-
tion induced by HC diet in mice.
2. Materials and methods
2.1. Plant material
Dried fruits fromX. aromatica (Lam.)Mart. were obtained in Curvelo,
Minas Gerais, in April andMayof 2010. The sampleswere identiﬁed by J.
Paula-Souza, and a voucher has been deposited in DATAPLAMT at the
Federal University of Minas Gerais (number DAT-110/2010).
2.2. Total phenol and ﬂavonoid content in X. aromatica fruits
Total phenol content was determined using the Folin–Ciocalteu
assay as described by Zielinski and Kozlowska (2000) with some
modiﬁcations. Total phenol sample solution (TPSS): Exactly 1 g of dried
powdered fruit was reﬂuxed with 50 ml of 60% methanol containing
0.1% HCl for 30 min and placed in water bath for 2 h at 85 °C to inacti-
vate the vitamin C (Georgé, Brat, Alter, & Amiot, 2005). After cooling,
the solution was ﬁltered and supplemented with 80% methanol to a
ﬁnal volume of 100 ml. Total phenol assay: Exactly 5 ml of TPSS was
transferred to a 25 ml volumetric ﬂask and completed with distilled
water. In a 25 ml volumetric ﬂask, 2 ml of the TPSS/water solution,
1 ml of Folin–Ciocalteu reagent and 10 ml of distilled water were com-
bined, and a 10.6% solution of anhydrous sodium carbonate was added
to bring the volume to 25 ml. After 30 min in the dark, the absorbance
at 760 nm was measured in a glass cuvette. Aqueous solutions of gallic
acid (0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 μg/ml) were used to obtain a standard
curve. The mean of three readings was used, and the results are
expressed as mg of gallic acid equivalents (GAE) per 100 mg of dry
weight.
The totalﬂavonoid contentwasmeasured by the aluminum chloride
assay as described by Amorim et al. (2008), with some modiﬁcations.
Sample preparation: Exactly 5 g of dried powdered fruit was reﬂuxed
with 50 ml of methanol for 45 min. After cooling, the solution was ﬁl-
tered, and methanol was added to a ﬁnal volume of 100 ml. A 5 ml ali-
quot of this solution, 0.6 ml of glacial acetic acid and 2.5 ml of 8%
aluminum chloride in methanol were added to a 25 ml volumetricﬂask, and methanol was added to bring the total volume to 25 ml.
After 30 min in the dark, the absorbance at 420 nm was measured in a
glass cuvette. Methanol solutions of rutin (5, 10, 20, 30 and 40 μg/ml)
were used to obtain a standard curve. The mean of three readings was
used, and the results are expressed as mg of rutin equivalents (RE) per
100 mg of dry weight.
2.3. Extract preparation
Dried and pulverized fruits were extracted by percolation with 95%
ethanol, and the solution was evaporated in a vacuum until dry
resulting in the crude extract (CEXA). The extractswere kept in a freezer
at−18 °C until further analysis.
2.3.1. Identiﬁcation of phenolics by TLC
The phytochemical screening of phenolics in the CEXA was per-
formed by thin layer chromatography. Approximately 10 mg of each
sample was dissolved in 1 ml of methanol. A small aliquot (10–20 μl)
was applied to an aluminum plate covered with silica gel. It was used
as an eluent, a mixture of ethyl acetate:acetic acid:formic acid:
water (100:11:11:26). The plate was revealed with 1% methanol
diphenylboric acid 2-amino-ethyl ester (NP) followed by 1% polyethyl-
ene glycol (PEG) 4000 in ethanol. The plate was heated for 5 min at
105 °C and then viewed under ultraviolet (UV) light at 365 nm. Samples
of rutin references, quercetin and chlorogenic acid were used for each
class of substance (Wagner & Bladt, 1996).
2.4. Quantiﬁcation of phenolics in CEXA by HPLC
The CEXA was analyzed in a Shimadzu HPLC with a DAD UV detec-
tor. The column used was an NST C18 (250 mm × 4.6 mm, 5 μm) at
40 °C, and the mobile phases comprised of acetonitrile, phosphoric
acid and water (7:0.4:92.6) (A) and acetonitrile and phosphoric acid
(99.6:0.4) (B). The gradient elutions occurred as follows: 100:0 (A:B)
for 0–17 min, 100:0 to 80:20 for 17–50 min, 80:20 to 0:100 for 50–
51 min, 0:100 for 51–61 min, 0:100 to 100:0 for 61–62 min and 100:0
for 62–72 min, with a ﬂow rate of 1 ml/min. The standards were pre-
pared in methanol at concentrations of 0.025 mg/ml for chlorogenic
and caffeic acids (Sigma-Aldrich®, São Paulo, SP, Brazil) and 0.07 mg/
ml for rutin (Sigma-Aldrich®, São Paulo, SP, Brazil) and quercetin
(Sigma-Aldrich®, São Paulo, SP, Brazil). The CEXA was prepared at
10 mg/ml, and the injection volume was 10 μl. The detection was per-
formed at 330 nm (Finzelberg, 2000).
2.5. Animals, diet, tissue and blood collection
Male BALB/c mice aged 4–5 weeks were obtained from the animal
care center at the Federal University of Minas Gerais (CEBIO/UFMG)
and were kept in an environmentally controlled room under a 14/10 h
light–dark cycle. Animals had free access to tap water and food and
were maintained according to the ethical guidelines of our institution.
The experimental protocol was approved by the Animal Ethics Commit-
tee at the university (CETEA/UFMG, number 211/2010). During the ﬁrst
8 weeks of the experiment, mice were divided in two groups: the ﬁrst
group (n = 8) received a control diet (LABINA), and the second group
(n = 32) received the HC diet. At the end of 8 weeks, the HC group
had glucose and lipid metabolic alterations and increased levels of in-
ﬂammatory parameters, just as described by Oliveira, Menezes-Garcia,
et al. (2012). TheHC diet was comprised of 45% condensedmilk, 10% re-
ﬁned sugar and 45% of the control diet. The macronutrient composition
of the control diet (4.0 kcal/g) was 65.8% by weight as carbohydrate,
3.1% as fat, and 31.1% as protein; and the HC diet (4.4 kcal/g) was
74.2% by weight as carbohydrate, 5.8% as fat, and 20% as protein.
The HC diet contained at least 30% reﬁned sugar (mostly sucrose)
(Oliveira, Menezes-Garcia, et al., 2012).
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redistributed equally into four groups. One group continued to re-
ceive the HC diet alone, whereas the other three groups had their
HC diet supplemented with three different concentrations of CEXA
(50, 100 and 200 mg/kg). This treatment was performed for four
weeks.
Mice were collectively housed, and food intake wasmeasured twice
a week for the ﬁrst eight weeks and daily during the last four weeks of
the experimental period. The body weight was measured once a week.
At the end of the dietary treatment, animals were anesthetizedwith ke-
tamine (130 mg/kg BW) and xylazine (0.3 mg/kg BW) and euthanized
by exsanguination. Liver, epididymal, retroperitoneal, and mesenteric
white adipose tissues were collected, weighed and stored at −20 °C
for further analysis. The adiposity index was calculated as percentage
of body fat (the sum of the epididymal, mesenteric and retroperitoneal
adipose tissue weight) divided by the total body weight. Blood was col-
lected, added to tubes and centrifuged (3000 rpm) for 10min at 4 °C to
obtain serum. The serumwas aliquoted into individual tubes and frozen
(−20 °C) to determine the glucose, triglyceride, cholesterol and insulin
levels.
2.6. Histology
Epididymal adipose tissue and liver were excised and ﬁxed in a
phosphate-buffered formaldehyde solution for 48 h and were then in-
cubated in 70% ethanol. Sections of the tissueswere stainedwith hema-
toxylin–eosin and analyzed in original magniﬁcation of 200×. In the
adipose tissue, the area encompassed by 100 adipocyte cells was mea-
sured in each animal using Image Pro-Plus software (Media Cybernet-
ics, USA). ImageJ (National Institutes of Health, Bethesda, Maryland,
USA)was used to calculate themean adipocyte area (μm2) and frequen-
cy distribution of adipocytes' cell surface area. Hepatic histological fea-
tures were investigated, and lesions were evaluated by a scoring
system of necroinﬂammation adapted from Brunt, Janney, Di Bisceglie,
Neuschwander-Tetri, and Bacon (1999). Inﬂammatory inﬁltrate,
perivascular inﬂammation and microsteatosis were classiﬁed by a
scoring system (0–3) consisting of the following grades: 0 = absent,
1 = mild, 2 = moderate, and 3 = severe.
2.7. Oral glucose tolerance and insulin sensitivity tests
For the oral glucose tolerance test, mice that were fasted overnight
orally received D-glucose (2 mg/kg BW). Tail blood samples were
taken at 0, 15, 30, 60 and 90 min after glucose administration, and the
blood glucose levels were measured using an Accu-Check glucometer
(Roche Diagnostics, Indianapolis, IN). The sensitivity test was per-
formed in fed mice after an intraperitoneal injection of insulin
(0.75 units/kg BW; Sigma, St. Louis, MO). Tail blood samples were
taken at 0, 15, 30 and 60 min after insulin injection to measure the
blood glucose levels.
2.8. Determination of serum parameters
Fasting glucose, triglycerides and total cholesterol levels were mea-
sured using enzymatic kits (Katal, Belo Horizonte, MG). The fasting
serum levels of insulin, adiponectin and resistin were assayed using
ELISA kits (Millipore, Missouri, USA). The homeostasis model of the
assessment for insulin resistance (HOMA-IR) and β cell function
(HOMA-β) was calculated as described by Matthews et al. (1985) and
updated by Bonora et al. (2000).
2.9. Total leukocyte, mononuclear cell and neutrophil counts
Tail blood samples were taken and diluted in 1:10 in Türk's solution.
Total leukocyte counts were performed using a Neubauer chamber. Pe-
ripheral blood smears were stained with May-Grünwald–Giemsa, anddifferential leukocyte counts were determined under oil immersion
(1000×) using standard morphology criteria.
2.10. ELISA assay
TNF-α, IL-6, IL-10, IL-4 and IL-13 levelsweremeasured in the epidid-
ymal adipose tissue and liver. These analyses were performed using
DuoSet ELISA development kits (R&D System, Inc., Minneapolis, MN,
USA) according to the manufacturer's instructions.
2.11. Statistical analysis
The data were analyzed statistically by one-way analysis of variance
(ANOVA) followedby the Student–Newman–Keuls test. Data and statis-
tical analyses were performed using GraphPad Prism version 4.0 for
Windows (GraphPad Software, San Diego California, USA). The results
were reported as the mean ± SD, and differences were considered to
be statistically signiﬁcant when P b 0.05.
3. Results
3.1. Total phenol and ﬂavonoid content in X. aromatica fruits
The total phenol content and the total ﬂavonoid content were 2.01±
0.06 mg GAE/100 mg and 0.07 ± 0.01 mg RE/100 mg, respectively.
Considering that the CEXA yield was 39.1%, the doses of 50 mg, 100 mg
and 200 mg of CEXA represent 2.57, 5.14 and 10.28 mg of GAE and 0.9,
1.8 and 3.6 mg of RE, respectively.
3.2. Chromatographic analysis
Phytochemical screening by TLC allowed for the identiﬁcation of the
ﬂavonoid rutin and caffeic and chlorogenic acids (data not shown).
HPLC analysis of CEXA (Fig. 1) indicated and quantiﬁed the presence
of 3 phenolic substances. Chlorogenic (0.22%) and caffeic (0.02%) acids
at Rt 9.64 and 11.78 min, respectively, and rutin (0.11%) at Rt 34.86
were identiﬁed.
3.3. Mice feeding CEXA had smaller adipocytes
The body weight gain, visceral adiposity index and adipocyte mor-
phology of the mice were evaluated. The body weight was similar be-
tween groups before and after the experimental period (data not
shown). There were no differences in food intake and body weight
gain (data not shown). However, the HC mice had a higher adiposity
index and increased adipocyte area compared to the control mice
(Fig. 2A). Although themice thatwere supplementedwith the three dif-
ferent doses of the CEXA showed no change in their adiposity index in
relation to animals that were fed the HC diet alone, they presented
with a smaller cell area (Fig. 2B). The animals that were fed the highest
concentration of the CEXA showed the smallest adipocyte cell size
(Fig. 2C, D).
3.4. CEXA improves glucose homeostasis but not serum lipid proﬁle
We examined if the addition of CEXA to the HC diet was sufﬁcient to
improve the glucose intolerance and dyslipidemia induced by the HC
diet. We used the performance oral glucose tolerance and insulin sensi-
tivity tests and analyzed fasting glucose, insulin levels and the lipid pro-
ﬁle as well as the HOMA indices. After 12 weeks on the HC diet, the
animals showed an elevated glycemic response to glucose overload
and a reduced response to insulin compared to animals fed the control
chow diet (Fig. 3). The fasting glucose levels, total cholesterol levels, tri-
glycerides and HOMA-IR increased, and decreased values of HOMA-β
were observed in mice fed the HC diet (Table 1). Mice that were fed
the HC diet supplemented with any of the CEXA doses evaluated
12
3
1 3[0,22%]
[0,02%] [0,11%]
2
Fig. 1.HPLC/DADchromatogramof the crude extract ofX. aromatica fruit. Retention times: (1)Rt: 9.64min, (2) Rt: 11.78min and (3)Rt: 35.86min, correspond, respectively, to chlorogenic acid,
caffeic acid and rutin. Concentrations of each class of substances are expressed as mg/100 mg between [ ]: 1 = 0.22 mg/100 mg; 2 = 0.02 mg/100 mg, 3 = 0.11 mg/100 mg.
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The highest dose of CEXA also improved the insulin sensitivity
(Fig. 3C, D) However, there were no differences in fasting glucose,
lipid proﬁle and HOMA indices in themice fed the HC diet supplement-
ed with CEXA (Table 1).A B
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cells (Fig. 4A, B). No differences in the neutrophil counts were observed
between all of the groups (Fig. 4C).
3.6. CEXA improved cytokine levels in liver and epididymal adipose tissue
To test if the CEXAmodulates the inﬂammation inmetabolic tissues,
we analyzed pro- and anti-inﬂammatory cytokines in adipose tissue
and liver. The HC group had higher values of TNF-α, IL-6, IL-4, IL-10
and IL-13 in the adipose tissue (Fig. 5) and the liver (Fig. 6) compared
to the control group. Supplementation of the HC diet with any of the
tested concentrations of CEXA reduced the levels of TNF-α and IL-6 in
the liver (Fig. 6A, B) but not in the adipose tissue (Fig. 5A, B). However,
CEXA at the highest dose increased the levels of the anti-inﬂammatory
cytokines IL-13 and IL-4 in both tissues (Figs. 5C, D; 6C, D). No changes
were observed in IL-10 levels in adipose tissue and liver after CEXA sup-
plementation (Figs. 5E, 6E).
3.7. Effect of CEXA on hepatic tissue
We evaluated if CEXA improves hepatic steatosis and inﬂammation
induced by an HC diet. Mice that were fed the HC diet showed higherTable 1
Effect of CEXA intake on fasting glucose, insulin, HOMA indices and serum lipids in mice fed w
CEXA. The data are presented as the mean ± SD (n = 8). *Signiﬁcant difference from the C gr
hydrate diet; HC50/HC100/HC200, animals fed with the HC diet plus 50, 100 or 200 mg/kg BW
Serum proﬁle Groups
Control HC
Fasting glucose (mg/dl) 167.8 ± 30.7 259.6 ± 93.9*
Insulin (ng/ml) 5.6 ± 0.8 5.9 ± 0.9
HOMA-IR 2.3 ± 0.3 3.9 ± 0.8*
HOMA-β 26.2 ± 9.9 14.1 ± 6.1*
Total cholesterol (mg/dl) 160.9 ± 23.3 326.6 ± 48.2*
Triacylglycerol (mg/dl) 199.7 ± 43.1 319.5 ± 46.7*inﬂammatory inﬁltrate, perivascular inﬂammation and microsteatosis
compared to mice that were fed the control diet (Fig. 7A, B). Animals
that received CEXA at all doses presented with a lower total histopath-
ological score compared to mice fed the HC diet alone (Fig. 7A).
4. Discussion
We ﬁrst had to determine the doses of CEXA that would be suitable
for this study. It is known that species within the same genus have sim-
ilar chemical substances. Laboratory studies with Xylopia aethiopica
fruits in animal models have shown positive effects on glucose and
lipid metabolism, as well as on metabolic dysfunction, which is
commonly associated with obesity (Ezekwesili, Nwodo, Eneh, &
Ogbunugafor, 2010; Nwozo et al., 2011; Ogbonnia et al., 2008, 2010).
An in vivo study showed an association of X. aethiopica fruits with
other plant extracts in reducing serum glucose and lipid parameters at
all of the four doses tested (50, 100, 250 and 500 mg/kg BW). An oral
gavage of X. aethiopica (250 mg/kg/ BW) in a hypercholesterolemic
mouse improved the lipid proﬁle and endogenous antioxidant enzymes
of the animals. Both reports primarily attributed the observed changes
to the phenolic substances and sterols present in the fruit. CEXA was
added to the animal feed in an attempt to mimic the ingestion of theith the C diet, HC diet alone and HC diet supplemented with 50, 100 or 200 mg/kg BW of
oup (P b 0.05). C, animals fed with the control diet; HC, animals fed with the high carbo-
of CEXA, respectively; CEXA, crude extract of Xylopia aromatica.
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Fig. 4. Total leukocyte count and differential count of mononuclear cells and neutrophils.
Total leukocyte count (A), mononuclear cell count (B) and neutrophil count (C) in mice
fed with the C diet, HC diet alone and HC diet supplemented with 50, 100 or 200 mg/kg
BW of CEXA. The data are presented as the mean ± SD (n = 8). *Signiﬁcant difference
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546 V.B. Oliveira et al. / Food Research International 62 (2014) 541–550fruit and its role as a functional food. Thedevelopment andmaintenance
of obesity and related metabolic disorders involve many complex mo-
lecular mechanisms and interconnected cell signaling pathways. In
this context, the multi-component nature of medicinal herbs appears
to be particularly suitable for treating complex diseases and offers
great potential for exerting synergistic actions (Yang et al., 2014).
Various bioactive substances in low concentrations are present in the
crude extract, which can act synergistically. Some teas as well as fruit
and vegetable extracts are a source of a complex mixture of bioactive
substances, and many studies have shown that they can provide health
beneﬁts through the combination of additive and synergistic effects
(Chantre & Lairon, 2002; Moreno, Ilic, Poulev, & Raskin, 2006; Seeram,
Adams, Hardy, & Heber, 2014).
There is signiﬁcant evidence of potential anti-obesity properties of
polyphenols, which include simple phenolic acids such as chlorogenic
and caffeic acids and ﬂavonols such as quercetin and rutin (Williams
et al., 2013). In this study, we quantiﬁed the total phenolic acid and
total ﬂavonoid levels by spectrophotometric analysis. CEXA showed
5.14% of GAE and 1.8% of RE. These values are similar to those of
other plant extracts that have been shown to positively affect in vivo
metabolic dysfunction models (Kang et al., 2012; Ortsäter, Grankvist,
Wolfram, Kuehn, & Sjöholm, 2012; Williams et al., 2013). A YerbaMate aqueous solution showed 5.6% of total phenolic acids and 0.3% of
ﬂavonoids (Bojić, Haas, & Maleš, 2013). The total phenolic levels in
green and black teas normally range from 3.2 to 14.7% (Prior & Cao,
1999). HPLC analysis showed that the major substances found in the
CEXAwere chlorogenic acid (0.22%) followed by other two unidentiﬁed
ﬂavonoids and rutin (0.11%), a quercetin glycoside. These polyphenols
are able to inhibit growth of adipose tissue by modulating adipocyte
metabolism (Badimon, Vilahur, & Padro, 2010; Morikawa, Ikeda,
Nonaka, & Suzuki, 2007). Hsu and Yen (2006) showed that chlorogenic
acid can suppress cell growth aswell as enhance cell apoptosis. Querce-
tin is a ﬂavonoid that has shown the most promise as a potential anti-
obesity treatment. Several reports have revealed that quercetin
improved the effects against obesity-related inﬂammation, including at-
tenuation of inﬂammationmarkers, insulin resistance andmacrophages
(Al-Fayez, Cai, Tunstall, Steward, & Gescher, 2006; Chuang et al., 2010).
The presence of these substances in CEXA probably contributed to the
positive results found in metabolic dysfunction mice.
In the present study, CEXAwas shown to improve oral glucose toler-
ance, insulin sensitivity, hepatic steatosis, and inﬂammatory responses
in adipose tissue and the liver. Although there were no observed chang-
es in body weight and adiposity, the animals that were fed with any of
the three doses of CEXA showed smaller adipocytes. The replacement
of the hypertrophic cells by young adipocytes could create amore favor-
ablemetabolic environment because smaller adipocytes aremore sensi-
tive to insulin (Okuno, Tamemoto, & Tobe, 1998). Some plant extracts
can reduce the size of adipocytes in obese and diabetic animals and
promote improvements in glucose metabolism (Chung, Cho, Bhuiyan,
Kim, & Lee, 2010; Kim et al., 2011; Krisanapun, Lee, Peungvicha,
Temsiririrkkul, & Baek, 2011). Although we observed positive results
on glucose metabolism, the addition of the three doses of CEXA in the
HC diet did not change HOMA-IR and HOMA-β, which are indices that
predict efﬁcient insulin function and insulin production by the pancre-
atic beta cells, respectively, in an indirect manner (Song et al., 2007).
It must be considered that these indices correlate to fasting glucose
and insulin, which are parameters that did not change between the
HC group and the HC mice supplemented with CEXA. Corroborating
with our results, other studies also showed that some plant extracts
improved the oral glucose tolerance but did not reduce fasting plasma
glucose (Akase et al., 2011; Mang et al., 2006).
CEXA improved glucosemetabolism in our study, butwe did not ob-
serve any alterations in lipid metabolism after CEXA consumption. Con-
trary to our ﬁndings, Nwozo et al. (2011) showed a reduction of
cholesterol levels and triglycerides in rats treated with X. aethiopica.
The authors attributed these results to the presence β-sitosterol in
X. aethiopica fruits, a compound that was neither identiﬁed nor quanti-
ﬁed in this report. Moreover, the dosage of the X. aethiopica extract used
was higher, and the length of the experiment was longer compared to
those in our study.
Mice receiving CEXA showed a decrease in the number of total leu-
kocytes and circulating mononuclear cells as well as reduced levels of
TNF-α and IL-6 in the liver, suggesting an improvement in the inﬂam-
matory environment induced by the HC diet. Several reports have
shown that obesity is a chronic low-grade inﬂammatory condition
(Hotamisligil, Shargill, & Spiegelman, 1993; Wellen & Hotamisligil,
2005). The expansion of visceral fat tissue produces a wide range of
pro- and anti-inﬂammatory mediators that have been linked to the de-
velopment of insulin resistance, glucose intolerance and hepatic
steatosis (Ferreira et al., 2011; Hotamisligil et al., 1993). Circulating im-
mune cells and cytokines are released by macrophages, lymphocytes,
and adipocytes to interact and regulate the inﬂammatory cascade and
metabolism (Nishimura et al., 2009; Pearson et al., 2003). It is well
documented that TNF-α and IL-6 stimulate increased transcription of
proinﬂammatory cytokines, which impairs the action of intracellular
tyrosine kinases and insulin activity in the liver and adipose
tissue (Schenk, Saberi, & Olefsky, 2008; Wellen & Hotamisligil, 2005).
Interestingly, there was no observed reduction in the levels of these
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Fig. 5. Concentration of inﬂammatorymediators in visceral adipose tissue. Levels of the cytokines TNF-α (A), IL-6 (B), IL-4 (C), IL-13 (D) and IL-10 (E) in the epididymal adipose tissue of
mice fedwith theCdiet, HCdiet alone andHCdiet supplementedwith 50, 100or 200 mg/kg BWof CEXA. Thedata arepresented as themean±SD (n=8). *Signiﬁcant difference from the
C group; #signiﬁcant difference from the HC group (P b 0.05). The groups are described in the legend of Fig. 2.
547V.B. Oliveira et al. / Food Research International 62 (2014) 541–550pro-inﬂammatory cytokines in adipose tissue, suggesting that CEXA
could modulate inﬂammation in mice in a cytokine and tissue-speciﬁc
manner.
Concomitant with the reduced levels of pro-inﬂammatory cytokines
in the liver, CEXA at the higher dose increased the levels of IL-4 and IL-
13 in adipose tissue and liver and improved livermicrosteatosis, inﬂam-
matory inﬁltrate and necrosis. Hepatic steatosis is a condition that is
commonly found in patients with obesity and type 2 diabetes and is
thought to be a major cause of hepatic insulin resistance (Lockman &
Nyirenda, 2010). Recent studies have shown that IL-4 and IL-13 amelio-
rate liver inﬂammation and ﬁbrosis (Das & Balakrishnan, 2011;
Shimamura et al., 2008). IL-4 also regulates glucosemetabolism by pro-
moting insulin sensitivity and glucose tolerance (Chang, Ho, Lu, Huang,
& Shiau, 2012; Winer & Winer, 2012). In accordance with our ﬁndings,
oral administration of Ilex paraguariensis extract rich in phenolics
(including chlorogenic acid and ﬂavonoids) showed signiﬁcant amelio-
rative effects on liver histopathology (Hussein et al., 2011).
The primary compounds in plant extracts possessing anti-
inﬂammatory and antioxidant activities are polyphenols, speciﬁcally
ﬂavonoids (Talhouk, Karam, Fostok, El-Jouni, & Barbour, 2007; Ueda,
Yamazaki, & Yamazaki, 2004). Flavonoids have been considered to
be a potential antidiabetic agent with hypoglycemic and anti-
hyperglycemic actions by mimicking and stimulating insulin secretion.
They also have actions similar to drugs such as metformin, which in-
creases insulin sensitivity but has no effect on its release (Chuanget al., 2010; Jung, Lee, Park, Kang, & Choi, 2006; Wu, Wu, Huang, Jao, &
Yen, 2009).
Previous studies have reported the presence of alkaloids and essen-
tial oils in X. aromatica fruits (Moraes & Roque, 1988; Silva, Miranda, &
Conceição, 2010). Alkaloids commonly found in spices have also
shown positive effects in metabolic complications associated with obe-
sity (Diwan et al., 2011; Kang et al., 2010), as well as essential oils
(Talpur, Echard, Ingram, Bagchi, & Preuss, 2005). However, it must be
considered that some alkaloids have hepatotoxic effects, and studies
of the global effect of higher intake of this fruit should be performed
(Li, Xia, Ruan, Fu, & Lin, 2011).
The higher concentration of anti-inﬂammatory interleukins in the
adipose tissue and liver of mice that received the highest dose of CEXA
likely contributed to the improvement on the insulin sensitivity test,
a reduced adipocyte size and lower histopathological score. These re-
sults can be explained by the increased amount of bioactive substances
present in the diet of the HC200 mice, and the biological activities ob-
served in this study are likely due to the set of all substances present
in CEXA.
Ourﬁndings showed that X. aromatica fruits canmodulatemetabolic
changes associated with obesity, especially those related to glucoseme-
tabolism. The beneﬁcial effects observed can be associated with a lower
release of inﬂammatory mediators in adipose tissue and the liver. This
study suggests the potential of X. aromatica in attenuating health
problems associated with metabolic dysfunction induced by poor diet.
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